These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20005259)

  • 1. Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia.
    Gilby DC; Sung HY; Winship PR; Goodeve AC; Reilly JT; Kiss-Toth E
    Immunol Lett; 2010 May; 130(1-2):115-24. PubMed ID: 20005259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
    Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Trib1 in myeloid leukaemogenesis and differentiation.
    Nakamura T
    Biochem Soc Trans; 2015 Oct; 43(5):1104-7. PubMed ID: 26517931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
    Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
    Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia.
    Keeshan K; He Y; Wouters BJ; Shestova O; Xu L; Sai H; Rodriguez CG; Maillard I; Tobias JW; Valk P; Carroll M; Aster JC; Delwel R; Pear WS
    Cancer Cell; 2006 Nov; 10(5):401-11. PubMed ID: 17097562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tribbles breaking bad: TRIB2 suppresses FOXO and acts as an oncogenic protein in melanoma.
    Link W
    Biochem Soc Trans; 2015 Oct; 43(5):1085-8. PubMed ID: 26517928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.
    Dedhia PH; Keeshan K; Uljon S; Xu L; Vega ME; Shestova O; Zaks-Zilberman M; Romany C; Blacklow SC; Pear WS
    Blood; 2010 Aug; 116(8):1321-8. PubMed ID: 20410507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nemo-like kinase blocks myeloid differentiation by targeting tumor suppressor C/EBPα in AML.
    Singh AK; Thacker G; Upadhyay V; Mishra M; Sharma A; Sethi A; Chowdhury S; Siddiqui S; Verma SP; Pandey A; Bhatt MLB; Trivedi AK
    FEBS J; 2024 Oct; 291(20):4539-4557. PubMed ID: 39110129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
    Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
    Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells.
    Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
    Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
    Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
    Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
    FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
    Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
    Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL uptake by monocytes in response to inflammation is MAPK dependent but independent of tribbles protein expression.
    Eder K; Guan H; Sung HY; Francis SE; Crossman DC; Kiss-Toth E
    Immunol Lett; 2008 Mar; 116(2):178-83. PubMed ID: 18308403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific.
    Sung HY; Francis SE; Crossman DC; Kiss-Toth E
    Immunol Lett; 2006 Apr; 104(1-2):171-7. PubMed ID: 16364454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
    Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
    Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells.
    Teo T; Yu M; Yang Y; Gillam T; Lam F; Sykes MJ; Wang S
    Cancer Lett; 2015 Feb; 357(2):612-23. PubMed ID: 25527453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun.
    Schepers H; Geugien M; van der Toorn M; Bryantsev AL; Kampinga HH; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jun; 33(6):660-70. PubMed ID: 15911090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia.
    Alachkar H; Mutonga MB; Metzeler KH; Fulton N; Malnassy G; Herold T; Spiekermann K; Bohlander SK; Hiddemann W; Matsuo Y; Stock W; Nakamura Y
    Oncotarget; 2014 Dec; 5(23):12371-82. PubMed ID: 25365263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.